Earnings
XBIO
4.170
+8.03%
0.310
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2021-12-31
1.16M
1.16M
--
--
3.74M
3.16M
--
--
--
6.91M
--
-5.75M
100.47K
--
1120.00
--
-5.65M
0.00
-5.65M
--
-5.65M
-5.65M
--
--
-0.55
FY 2020-12-31
436.94K
436.94K
--
--
3.40M
1.73M
--
--
--
14.37M
--
-13.94M
126.17K
--
-490.00
--
-13.81M
-2.92M
-10.89M
--
-10.89M
-10.89M
--
--
-1.70
FY 2019-12-31
17.07K
17.07K
--
--
3.63M
1.86M
--
--
--
12.90M
--
-12.89M
108.49K
--
3320.00
--
-12.78M
--
-12.78M
--
-12.78M
-18.06M
--
--
-6.33
FY 2018-12-31
0.00
0.00
0.00
0.00
4.39M
2.88M
--
--
--
7.28M
--
-7.28M
510.00
--
-24.64K
--
-7.30M
--
-7.30M
--
-7.30M
-7.30M
--
--
-9.66
FY 2017-12-31
7.58M
7.58M
156.12K
7.43M
6.94M
4.06M
--
--
--
11.15M
--
-3.57M
14.72K
--
-41.10K
--
-3.60M
0.00
-3.60M
--
-3.60M
-3.60M
0.00
--
-4.98

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.